Showing results (51-60 of 731) with videos related to
Sort By:
Pageof 74
Trends in Cancer|July 26, 2017
Re-Evaluating Clonal Dominance in Cancer EvolutionRebecca A Burrell, Charles SwantonCancer Discovery|February 7, 2016
Pruning Cancer's Evolutionary Tree with Lesion-Directed TherapyCrispin T Hiley, Charles SwantonClinical Medicine (London, England)|December 4, 2014
Spatial and temporal cancer evolution: causes and consequences of tumour diversityCrispin T Hiley, Charles SwantonCurrent Opinion in Genetics & Development|March 25, 2014
The evolution of the unstable cancer genomeRebecca A Burrell, Charles SwantonThe EPMA Journal|June 29, 2012
Unlocking Pandora's box: personalising cancer cell death in non-small cell lung cancerDean A Fennell, Charles SwantonBMC Medicine|July 19, 2017
The role of tumour heterogeneity and clonal cooperativity in metastasis, immune evasion and clinical outcomeDeborah R Caswell, Charles SwantonMolecular Oncology|August 5, 2014
Tumour heterogeneity and the evolution of polyclonal drug resistanceRebecca A Burrell, Charles SwantonJournal for Immunotherapy of Cancer|September 16, 2022
Oral beclomethasone dipropionate is an effective treatment for immune checkpoint inhibitor induced colitisJames L Alexander, Hajir Ibraheim, Camellia Richards, et al.Nature Ecology & Evolution|May 18, 2021
Selection of metastasis competent subclones in the tumour interiorYue Zhao, Xiao Fu, Jose I Lopez, et al.Pageof 74